Stockreport

Cue Biopharma, Inc. (CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases Transcript [Seeking Alpha]

Cue Biopharma, Inc.  (CUE) 
US:NASDAQ Investor Relations: cuebiopharma.gcs-web.com/news-releases
PDF Company Participants Lucinda Warren - Interim CEO, Interim President,Principal Fin & Accounting Off., Chief Financial & Business Off. Daniel Baker - Interim Chief D [Read more]